Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients
Authors
Keywords
Interleukin-37, Epithelial ovarian cancer, Prognosis, Biomarker
Journal
ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Volume 295, Issue 2, Pages 459-465
Publisher
Springer Nature
Online
2016-12-14
DOI
10.1007/s00404-016-4258-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-37 (IL-1F7) the Newest Anti-Inflammatory Cytokine Which Suppresses Immune Responses and Inflammation
- (2017) S. Tetè et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer
- (2016) Guanqun Ge et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- IL-37b suppresses T cell priming by modulating dendritic cell maturation and cytokine production via dampening ERK/NF-κB/S6K signalings
- (2015) Wantong Wu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer
- (2015) Jiheum Paek et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer
- (2015) Li-ying Zhang et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Tumor Infiltrating Lymphocytes in Ovarian Cancer
- (2015) Maria Luisa Gasparri et al. Asian Pacific Journal of Cancer Prevention
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor infiltrating lymphocytes in ovarian cancer
- (2015) Phillip P Santoiemma et al. CANCER BIOLOGY & THERAPY
- Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity
- (2015) Bingni Chen et al. Journal of Translational Medicine
- IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury
- (2015) Yunbo Yang et al. KIDNEY INTERNATIONAL
- Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells
- (2015) Xu Shuai et al. Scientific Reports
- RETRACTED: IL-37 reduces inflammatory response after cerebral ischemia and reperfusion injury through down-regulation of pro-inflammatory cytokines
- (2014) Faye J. Patel et al. CYTOKINE
- IL-37 Ameliorates the Inflammatory Process in Psoriasis by Suppressing Proinflammatory Cytokine Production
- (2014) X. Teng et al. JOURNAL OF IMMUNOLOGY
- Intestinal Expression of the Anti-Inflammatory Interleukin-1 Homologue IL-37 in Pediatric Inflammatory Bowel Disease
- (2014) Simon Weidlich et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity
- (2014) Liang Ye et al. Journal of Translational Medicine
- Plasma Levels of IL-37 and Correlation with TNF-α, IL-17A, and Disease Activity during DMARD Treatment of Rheumatoid Arthritis
- (2014) Ping-Wei Zhao et al. PLoS One
- Increased Expression of IL-37 in Patients with Graves' Disease and Its Contribution to Suppression of Proinflammatory Cytokines Production in Peripheral Blood Mononuclear Cells
- (2014) Yanqun Li et al. PLoS One
- IL-37 protects against obesity-induced inflammation and insulin resistance
- (2014) Dov B. Ballak et al. Nature Communications
- Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells
- (2014) Jing-Jing Zhao et al. Scientific Reports
- Prognostic Significance of Serum Soluble CD163 Level in Patients with Epithelial Ovarian Cancer
- (2013) Jae Hong No et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Elevated Levels of Cerebrospinal Fluid and Plasma Interleukin-37 in Patients with Guillain-Barré Syndrome
- (2013) Cong Li et al. MEDIATORS OF INFLAMMATION
- Ovarian Cancer
- (2012) JESSICA HUNN et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells
- (2012) Nozomu Sakai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Therapeutic opportunities for manipulating TReg cells in autoimmunity and cancer
- (2012) Harald von Boehmer et al. NATURE REVIEWS DRUG DISCOVERY
- Interleukin 37 expression protects mice from colitis
- (2011) E. N. McNamee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-37 is a fundamental inhibitor of innate immunity
- (2010) Marcel F Nold et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started